Sarissa Capital Management LP Alkermes Plc. Transaction History

Sarissa Capital Management LP

  • $402 Million
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$27.17 - $31.97 $190 Million - $224 Million
-6,997,800 Reduced 49.84%
7,042,200 $197 Million
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $144 Million - $171 Million
5,075,360 Added 56.62%
14,040,000 $439 Million
Q4 2022

Feb 14, 2023
SELL
$21.94 - $26.24 $111 Million - $133 Million
-5,075,360 Reduced 36.15%
8,964,640 $234 Million
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $17.8 Million - $26.5 Million
827,000 Added 6.26%
14,040,000 $327 Million
Q3 2021

Nov 15, 2021
BUY
$23.37 - $32.13 $31.4 Million - $43.2 Million
1,343,000 Added 11.31%
13,213,000 $407 Million
Q2 2021

Aug 16, 2021
BUY
$18.78 - $25.15 $73.6 Million - $98.6 Million
3,920,000 Added 49.31%
11,870,000 $291 Million
Q4 2020

Feb 16, 2021
BUY
$15.39 - $22.1 $1.92 Million - $2.76 Million
125,000 Added 1.6%
7,950,000 $159 Million
Q2 2020

Aug 14, 2020
BUY
$13.31 - $19.41 $8.41 Million - $12.3 Million
632,000 Added 8.79%
7,825,000 $152 Million
Q1 2020

May 15, 2020
BUY
$13.06 - $21.24 $44.2 Million - $72 Million
3,388,000 Added 89.04%
7,193,000 $104 Million
Q4 2019

Feb 14, 2020
BUY
$17.29 - $21.74 $65.8 Million - $82.7 Million
3,805,000 New
3,805,000 $77.6 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Sarissa Capital Management LP Portfolio

Follow Sarissa Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email